Provided by Tiger Fintech (Singapore) Pte. Ltd.

Vertex Pharmaceuticals

450.50
+6.681.51%
Post-market: 450.500.00000.00%18:58 EDT
Volume:960.50K
Turnover:431.61M
Market Cap:115.69B
PE:-117.27
High:451.66
Open:443.83
Low:443.83
Close:443.82
Loading ...

Prediction: These 2 Stocks Will Outperform the Market in the Next Five Years

Motley Fool
·
12 May

Can Buying CRISPR Therapeutics and Holding It Forever Make You a Millionaire?

Motley Fool
·
12 May

My Favorite Tariff Safe-Haven Stock to Buy on the Dip

Motley Fool
·
10 May

S&P 500 Posts Weekly Decline as Health Care, Communication Services Drop

MT Newswires Live
·
10 May

4 No-Brainer Stocks to Buy Right Now

Motley Fool
·
09 May

Vertex Pharmaceuticals Inc. Stock Outperforms Competitors Despite Losses On The Day

Dow Jones
·
09 May

Vertex Minerals Initiates Trading Halt for Capital Raising Announcement

TIPRANKS
·
08 May

Vertex (VERX) Gets a Buy from Jefferies

TIPRANKS
·
08 May

Vertex Q1 Non-GAAP Earnings Unchanged, Revenue Rises; 2025 Sales Outlook Steady

MT Newswires Live
·
07 May

Vertex Q1 Adj. EPS $0.15 Beats $0.13 Estimate, Sales $177.06M Beat $176.97M Estimate

Benzinga
·
07 May

Wolfe Research Downgrades Vertex Pharmaceuticals to Peer Perform From Outperform

MT Newswires Live
·
07 May

Why Vertex Pharmaceuticals Stock Is a Screaming Buy on the Dip

Motley Fool
·
07 May

Analysts’ Opinions Are Mixed on These Healthcare Stocks: Vertex Pharmaceuticals (VRTX), Waters (WAT) and ZimVie Inc (ZIMV)

TIPRANKS
·
07 May

Barclays Reaffirms Their Hold Rating on Vertex Pharmaceuticals (VRTX)

TIPRANKS
·
07 May

Vertex Appoints Joint CFO

MT Newswires Live
·
07 May

Vertex Pharmaceuticals’ Earnings Call Highlights Growth and Challenges

TIPRANKS
·
07 May

Post-Bell | U.S. Stocks Close Lower; Pony AI Soars 48%; WeRide Surges 32%; Hims & Hers Jumps 18%; Tesla Drops 2%

Tiger Newspress
·
07 May

RPT-US STOCKS-Equities close lower as tariff uncertainty weighs

Reuters
·
07 May

Vertex downgraded to Peer Perform from Outperform at Wolfe Research

TIPRANKS
·
07 May

Vertex Pharmaceuticals price target raised to $621 from $617 at Goldman Sachs

TIPRANKS
·
07 May